Next Article in Journal
Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice
Next Article in Special Issue
Roles of Copper-Binding Proteins in Breast Cancer
Previous Article in Journal
Bioethics of Clinical Applications of Stem Cells
Previous Article in Special Issue
Administration of Zinc plus Cyclo-(His-Pro) Increases Hippocampal Neurogenesis in Rats during the Early Phase of Streptozotocin-Induced Diabetes
Review

Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker

by 1,2 and 1,2,*
1
Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan
2
Kawasaki Disease Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan
*
Author to whom correspondence should be addressed.
Academic Editor: Reinhard Dallinger
Int. J. Mol. Sci. 2017, 18(4), 820; https://doi.org/10.3390/ijms18040820
Received: 9 March 2017 / Revised: 5 April 2017 / Accepted: 11 April 2017 / Published: 12 April 2017
(This article belongs to the Special Issue Metal Metabolism in Animals II)
Kawasaki disease (KD) is an autoimmune-like disease and acute childhood vasculitis syndrome that affects various systems but has unknown etiology. In addition to the standard diagnostic criteria, anemia is among the most common clinical features of KD patients and is thought to have a more prolonged duration of active inflammation. In 2001, the discovery of a liver-derived peptide hormone known as hepcidin began revolutionizing our understanding of anemia’s relation to a number of inflammatory diseases, including KD. This review focuses on hepcidin-induced iron deficiency’s relation to transient hyposideremia, anemia, and disease outcomes in KD patients, and goes on to suggest possible routes of further study. View Full-Text
Keywords: anemia; hepcidin; Kawasaki disease; iron deficiency anemia; hepcidin; Kawasaki disease; iron deficiency
Show Figures

Graphical abstract

MDPI and ACS Style

Huang, Y.-H.; Kuo, H.-C. Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker. Int. J. Mol. Sci. 2017, 18, 820. https://doi.org/10.3390/ijms18040820

AMA Style

Huang Y-H, Kuo H-C. Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker. International Journal of Molecular Sciences. 2017; 18(4):820. https://doi.org/10.3390/ijms18040820

Chicago/Turabian Style

Huang, Ying-Hsien, and Ho-Chang Kuo. 2017. "Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker" International Journal of Molecular Sciences 18, no. 4: 820. https://doi.org/10.3390/ijms18040820

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop